{"count": 9, "results": [{"_id": "10716459", "pmid": 10716459, "title": "Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).", "journal": "J Am Coll Cardiol", "authors": ["Jørgensen B", "Simonsen S", "Endresen K", "Forfang K", "Vatne K", "Hansen J", "Webb J", "Buller C", "Goulet G", "Erikssen J", "Thaulow E"], "date": "2000-03-01T00:00:00Z", "doi": "10.1016/s0735-1097(99)00599-9", "meta_date_publication": "2000 Mar 1", "meta_volume": "35", "meta_issue": "3", "meta_pages": "592-9", "score": 50092.496, "text_hl": "@<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@Restenosis@@@ and clinical outcome in @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ after angioplasty: results from the Coronary AngioPlasty @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@REStenosis@@@ Study (CAPARES).", "citations": {"NLM": "Jørgensen B, Simonsen S, Endresen K, Forfang K, Vatne K, Hansen J, Webb J, Buller C, Goulet G, Erikssen J, Thaulow E. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES). J Am Coll Cardiol. 2000 Mar 1;35(3):592-9. PMID: 10716459", "BibTeX": "@article{10716459, title={Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).}, author={Jørgensen B and Simonsen S and Endresen K and Forfang K and Vatne K and Hansen J and Webb J and Buller C and Goulet G and Erikssen J and Thaulow E}, journal={J Am Coll Cardiol}, volume={35}, number={3}, pages={592-9}}"}}, {"_id": "10071258", "pmid": 10071258, "title": "Pharmacologic effects of calcium channel blockers on restenosis.", "journal": "J Cardiovasc Pharmacol", "authors": ["Thaulow E"], "date": "1999-01-01T00:00:00Z", "doi": "10.1097/00005344-199900002-00004", "meta_date_publication": "1999", "meta_volume": "33 Suppl 2", "meta_issue": "", "meta_pages": "S12-6", "score": 50079.992, "text_hl": "The Coronary Angioplasty @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@Restenosis@@@ Study (CAPARES) is therefore assessing the effect of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, a long-acting, third-generation calcium channel blocker in angioplasty @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Thaulow E. Pharmacologic effects of calcium channel blockers on restenosis. J Cardiovasc Pharmacol. 1999;33 Suppl 2():S12-6. PMID: 10071258", "BibTeX": "@article{10071258, title={Pharmacologic effects of calcium channel blockers on restenosis.}, author={Thaulow E}, journal={J Cardiovasc Pharmacol}, volume={33 Suppl 2}, pages={S12-6}}"}}, {"_id": "10071259", "pmid": 10071259, "title": "Atheroprotection with amlodipine: cells to lesions and the PREVENT trial. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial.", "journal": "J Cardiovasc Pharmacol", "authors": ["Tulenko TN", "Brown J", "Laury-Kleintop L", "Khan M", "Walter MF", "Mason RP"], "date": "1999-01-01T00:00:00Z", "doi": "10.1097/00005344-199900002-00005", "meta_date_publication": "1999", "meta_volume": "33 Suppl 2", "meta_issue": "", "meta_pages": "S17-22", "score": 50077.29, "text_hl": "Recent animal model studies have demonstrated that @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ inhibits the progression of @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerotic lesions@@@ and protects against @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@restenosis@@@ after angioplasty. ", "citations": {"NLM": "Tulenko TN, Brown J, Laury-Kleintop L, Khan M, Walter MF, Mason RP. Atheroprotection with amlodipine: cells to lesions and the PREVENT trial. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial. J Cardiovasc Pharmacol. 1999;33 Suppl 2():S17-22. PMID: 10071259", "BibTeX": "@article{10071259, title={Atheroprotection with amlodipine: cells to lesions and the PREVENT trial. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial.}, author={Tulenko TN and Brown J and Laury-Kleintop L and Khan M and Walter MF and Mason RP}, journal={J Cardiovasc Pharmacol}, volume={33 Suppl 2}, pages={S17-22}}"}}, {"_id": "12104059", "pmid": 12104059, "title": "A pharmacoeconomic evaluation of results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) in Norway and Canada.", "journal": "Int J Cardiol", "authors": ["Thaulow E", "Jorgensen B", "Doyle JJ", "Casciano R", "Casciano J", "Kopp Z", "Arikian S", "Kim R"], "date": "2002-07-01T00:00:00Z", "doi": "10.1016/s0167-5273(02)00113-4", "meta_date_publication": "2002 Jul", "meta_volume": "84", "meta_issue": "1", "meta_pages": "23-30; discussion 30-2", "score": 50076.9, "text_hl": "A pharmacoeconomic evaluation of results from the Coronary Angioplasty @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@Restenosis@@@ Study (CAPARES) in Norway and Canada.", "citations": {"NLM": "Thaulow E, Jorgensen B, Doyle JJ, Casciano R, Casciano J, Kopp Z, Arikian S, Kim R. A pharmacoeconomic evaluation of results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) in Norway and Canada. Int J Cardiol. 2002 Jul;84(1):23-30; discussion 30-2. PMID: 12104059", "BibTeX": "@article{12104059, title={A pharmacoeconomic evaluation of results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) in Norway and Canada.}, author={Thaulow E and Jorgensen B and Doyle JJ and Casciano R and Casciano J and Kopp Z and Arikian S and Kim R}, journal={Int J Cardiol}, volume={84}, number={1}, pages={23-30; discussion 30-2}}"}}, {"_id": "16406672", "pmid": 16406672, "title": "Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.", "journal": "Pharmacol Res", "authors": ["Rossetti F", "De Portu S", "Menditto E", "Scalone L", "Bustacchini S", "Cricelli C", "Mantovani LG"], "date": "2006-03-01T00:00:00Z", "doi": "10.1016/j.phrs.2005.10.002", "meta_date_publication": "2006 Mar", "meta_volume": "53", "meta_issue": "3", "meta_pages": "197-201", "score": 50067.918, "text_hl": "Information on clinical outcomes was drawn from the Coronary Angioplasty @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@Restenosis@@@ Study (CAPARES). ", "citations": {"NLM": "Rossetti F, De Portu S, Menditto E, Scalone L, Bustacchini S, Cricelli C, Mantovani LG. Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA. Pharmacol Res. 2006 Mar;53(3):197-201. PMID: 16406672", "BibTeX": "@article{16406672, title={Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.}, author={Rossetti F and De Portu S and Menditto E and Scalone L and Bustacchini S and Cricelli C and Mantovani LG}, journal={Pharmacol Res}, volume={53}, number={3}, pages={197-201}}"}}, {"_id": "15056829", "pmid": 15056829, "title": "Effect of amlodipine on vascular responses after coronary stenting compared with an angiotensin-converting enzyme inhibitor.", "journal": "Circ J", "authors": ["Yamazaki T", "Taniguchi I", "Kurusu T", "Shimazu Y", "Hashizume Y", "Takikawa K", "Kuwata M", "Onodera T", "Yoshikawa M", "Mochizuki S"], "date": "2004-04-01T00:00:00Z", "doi": "10.1253/circj.68.328", "meta_date_publication": "2004 Apr", "meta_volume": "68", "meta_issue": "4", "meta_pages": "328-33", "score": 50067.086, "text_hl": "We compared @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Quinapril @CHEMICAL_MESH:D000077583 @@@quinapril@@@ to determine which is more effective in preventing @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@restenosis@@@ after stenting. ", "citations": {"NLM": "Yamazaki T, Taniguchi I, Kurusu T, Shimazu Y, Hashizume Y, Takikawa K, Kuwata M, Onodera T, Yoshikawa M, Mochizuki S. Effect of amlodipine on vascular responses after coronary stenting compared with an angiotensin-converting enzyme inhibitor. Circ J. 2004 Apr;68(4):328-33. PMID: 15056829", "BibTeX": "@article{15056829, title={Effect of amlodipine on vascular responses after coronary stenting compared with an angiotensin-converting enzyme inhibitor.}, author={Yamazaki T and Taniguchi I and Kurusu T and Shimazu Y and Hashizume Y and Takikawa K and Kuwata M and Onodera T and Yoshikawa M and Mochizuki S}, journal={Circ J}, volume={68}, number={4}, pages={328-33}}"}}, {"_id": "9152666", "pmid": 9152666, "title": "Clinical promise of calcium antagonists in the angioplasty patient.", "journal": "Eur Heart J", "authors": ["Thaulow E", "Jörgensen B"], "date": "1997-05-01T00:00:00Z", "doi": "10.1093/eurheartj/18.suppl_b.21", "meta_date_publication": "1997 May", "meta_volume": "18 Suppl B", "meta_issue": "", "meta_pages": "B21-6", "score": 50062.375, "text_hl": "The Coronary Angioplasty @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ in @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@Restenosis@@@ (CAPARES) trial has been initiated to assess the impact of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ upon the rate of @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@restenosis@@@ and @DISEASE_Angina_Pectoris @DISEASE_MESH:D000787 @@@angina@@@/@DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischaemia@@@ after the procedure.", "citations": {"NLM": "Thaulow E, Jörgensen B. Clinical promise of calcium antagonists in the angioplasty patient. Eur Heart J. 1997 May;18 Suppl B():B21-6. PMID: 9152666", "BibTeX": "@article{9152666, title={Clinical promise of calcium antagonists in the angioplasty patient.}, author={Thaulow E and Jörgensen B}, journal={Eur Heart J}, volume={18 Suppl B}, pages={B21-6}}"}}, {"_id": "12660661", "pmid": 12660661, "title": "An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.", "journal": "Am Heart J", "authors": ["Dens J", "Desmet W", "Piessens J"], "date": "2003-03-01T00:00:00Z", "doi": "10.1067/mhj.2003.171", "meta_date_publication": "2003 Mar", "meta_volume": "145", "meta_issue": "3", "meta_pages": "404-8", "score": 50058.242, "text_hl": "Recently, the results of 2 large similar trials (@CHEMICAL_Nisoldipine @CHEMICAL_MESH:D015737 @@@Nisoldipine@@@ In @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@Coronary Artery Disease@@@ in Leuven [NICOLE], and @DISEASE_Coronary_Aneurysm @DISEASE_MESH:D003323 @@@Coronary AngioPlasty@@@ @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ in @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@REstenosis@@@ Study [CAPARES]) were published. ", "citations": {"NLM": "Dens J, Desmet W, Piessens J. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty. Am Heart J. 2003 Mar;145(3):404-8. PMID: 12660661", "BibTeX": "@article{12660661, title={An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.}, author={Dens J and Desmet W and Piessens J}, journal={Am Heart J}, volume={145}, number={3}, pages={404-8}}"}}, {"_id": "9488193", "pmid": 9488193, "title": "Effects of amlodipine on gene expression and extracellular matrix formation in human vascular smooth muscle cells and fibroblasts: implications for vascular protection.", "journal": "Int J Cardiol", "authors": ["Eickelberg O", "Roth M", "Block LH"], "date": "1997-12-31T00:00:00Z", "doi": "10.1016/s0167-5273(97)00239-8", "meta_date_publication": "1997 Dec 31", "meta_volume": "62 Suppl 2", "meta_issue": "", "meta_pages": "S31-7", "score": 50053.484, "text_hl": "Vascular smooth muscle cells (VSMC) are involved in the pathogenesis of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@coronary artery disease@@@. @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, a calcium channel blocker of the @CHEMICAL_1_4_dihydropyridine @CHEMICAL_MESH:C038806 @@@dihydropyridine@@@ type, is widely used in the therapy of these diseases, and has been shown to reduce the progression of the underlying pathophysiological mechanisms, such as @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerosis@@@ and @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@restenosis@@@. ", "citations": {"NLM": "Eickelberg O, Roth M, Block LH. Effects of amlodipine on gene expression and extracellular matrix formation in human vascular smooth muscle cells and fibroblasts: implications for vascular protection. Int J Cardiol. 1997 Dec 31;62 Suppl 2():S31-7. PMID: 9488193", "BibTeX": "@article{9488193, title={Effects of amlodipine on gene expression and extracellular matrix formation in human vascular smooth muscle cells and fibroblasts: implications for vascular protection.}, author={Eickelberg O and Roth M and Block LH}, journal={Int J Cardiol}, volume={62 Suppl 2}, pages={S31-7}}"}}]}